Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G DuBois

Showing results (1-10 of 262) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2021
Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized TrialsSteven G DuBois, Rochelle Bagatell
Cancer Medicine|October 28, 2022
Early Termination of Oncology Clinical Trials in the United StatesEllen Zhang, Steven G DuBois
Pediatric Blood & Cancer|March 12, 2019
Winning the RACE: Expanding pediatric cancer drug approvalsDavid S Shulman, Steven G DuBois
Paediatric Drugs|January 23, 2020
The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric CancersDavid S Shulman, Steven G DuBois
Nature Reviews. Clinical Oncology|April 25, 2009
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcomaSteven G DuBois, Holcombe E Grier
The New England Journal of Medicine|October 11, 2018
Neuroblastoma and Histone DemethylationSteven G DuBois, Julie R Park
Nuclear Medicine and Biology|December 4, 2008
Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaSteven G DuBois, Katherine K Matthay
Clinical Trials (London, England)|November 14, 2023
Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trialsAvina Rami, Steven G DuBois, Kevin Campbell
Current Opinion in Pediatrics|December 3, 2019
New approaches to therapeutic drug development for childhood cancersKevin Campbell, Clement Ma, Steven G DuBois
Paediatric Drugs|April 4, 2023
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging AgentsBhuvana A Setty, Ajami Gikandi, Steven G DuBois
Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2021
Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized TrialsSteven G DuBois, Rochelle Bagatell
Cancer Medicine|October 28, 2022
Early Termination of Oncology Clinical Trials in the United StatesEllen Zhang, Steven G DuBois
Pediatric Blood & Cancer|March 12, 2019
Winning the RACE: Expanding pediatric cancer drug approvalsDavid S Shulman, Steven G DuBois
Paediatric Drugs|January 23, 2020
The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric CancersDavid S Shulman, Steven G DuBois
Nature Reviews. Clinical Oncology|April 25, 2009
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcomaSteven G DuBois, Holcombe E Grier
The New England Journal of Medicine|October 11, 2018
Neuroblastoma and Histone DemethylationSteven G DuBois, Julie R Park
Nuclear Medicine and Biology|December 4, 2008
Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaSteven G DuBois, Katherine K Matthay
Clinical Trials (London, England)|November 14, 2023
Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trialsAvina Rami, Steven G DuBois, Kevin Campbell
Current Opinion in Pediatrics|December 3, 2019
New approaches to therapeutic drug development for childhood cancersKevin Campbell, Clement Ma, Steven G DuBois
Paediatric Drugs|April 4, 2023
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging AgentsBhuvana A Setty, Ajami Gikandi, Steven G DuBois
Pageof 27